The Christie NHS Foundation Trust

Organisation as named by public health-data sources.

Records naming this organisation

• This study will look at two drugs, Nivolumab and Pembrolizumab, to work out the amount of wastage that happens when a patient’s weight is used to calculate their specific dose during chemotherapy tre… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-09-06)
• This study will look at two drugs, Nivolumab and Pembrolizumab, to work out the amount of wastage that happens when a patient’s weight is used to calculate their specific dose during chemotherapy tre… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-10-24)
• This service evaluation will investigate why there are differences in the stage of cancer diagnosis within the Greater Manchester and Eastern Cheshire regions, and where improvement is needed in orde… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-12-11)
• This audit will look at how patients with non-small cell lung cancer (NSCLC) are treated by the NHS with a type of second line chemotherapy called docetaxel, which is either administered on its own o… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-01-09)
• This project will look at the differences in breast cancer clinical pathways which lead to tertiary care (specialised cancer management) in Greater Manchester, and centred on The Christie NHS Foundat… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-01-17)
• This project will look at the differences in breast cancer clinical pathways which lead to tertiary care (specialised cancer management) in Greater Manchester, and centred on The Christie NHS Foundat… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-01-17)
• This project will look at the differences in breast cancer clinical pathways which lead to tertiary care (specialised cancer management) in Greater Manchester, and centred on The Christie NHS Foundat… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-01-17)
• This project will look at the differences in breast cancer clinical pathways which lead to tertiary care (specialised cancer management) in Greater Manchester, and centred on The Christie NHS Foundat… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-04-10)
• This project aims to understand the link between the dose of radiotherapy treatment used to treat patients with lung cancer and the potential damage caused to surrounding organs, including the heart. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-04-30)
• This audit will look at how patients with non-small cell lung cancer (NSCLC) are treated by the NHS with a type of second line chemotherapy called docetaxel, which is either administered on its own o… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-11-20)

Organisation name as the register gives it. Not matched to a company or institutional identifier here; the same organisation may appear under other spellings.